[A controlled double-blind crossover study of the efficacy of mepiprazol (EMD 16.923) and of diazepam in the treatment of neurotic disorders].

Abstract

After a preliminary encouraging trial of mepiprazol (EMD 16.923) on 8 patients, a double-blind cross-over study of mepiprazol and diazepam was performed in order to compare their effect in the treatment of neurotic disorders, particularly on various forms of anxiety.

• Authors: R De Buck, R Van Durme, I Pelc
• Journal: Acta psychiatrica Belgica (Acta Psychiatr Belg) Vol. 75 Issue 3 Pg. 320-33 (May 1975) ISSN: 0300-8967 [Print] Belgium
• Vernacular Title: Etude contrôlée selon la méthode du double insu cross over de l'efficacit-57e compar-57ee du mepiprazol (EMD 16.923) et du diazepam dans le traitement des troubles n-57evrotiques
• PMID: 769484 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, English Abstract, Journal Article)

Chemical References

• Piperazines
• Pyrazoles
• Tranquilizing Agents
• Diazepam

Topics

• Adult
• Anxiety Disorders (drug therapy)
• Clinical Trials as Topic
• Diazepam (adverse effects, therapeutic use)
• Female
• Humans
• Male
• Middle Aged
• Neurotic Disorders (drug therapy)
• Piperazines (therapeutic use)
• Pyrazoles (therapeutic use)
• Self-Assessment
• Tranquilizing Agents (therapeutic use)